XML 47 R16.htm IDEA: XBRL DOCUMENT

Warrants	12 Months Ended
Dec. 31, 2021
Warrants And Rights Note Disclosure [Abstract]
Warrants	9. Warrants Convertible Preferred Stock Warrants On the closing of the IPO, the 64,003 aggregate outstanding convertible preferred stock warrants converted into 64,003 common stock warrants with an exercise price of $8.64 per share, which resulted in the reclassification of the convertible preferred stock warrant liability of $0.5 million to additional paid-in capital. In September 2021, all of these common stock warrants were net exercised into 31,460 shares of common stock. Common Stock Warrants In September 2021, common stock warrants to purchase 38,058 shares of the Company’s stock were net exercised into 33,188 shares of common stock, which resulted in the reclassification of the common stock warrant liability of $1.2 million to additional paid-in capital.

Warrants

12 Months Ended

Dec. 31, 2021

Warrants And Rights Note Disclosure [Abstract]

9. Warrants

Convertible Preferred Stock Warrants

On the closing of the IPO, the 64,003 aggregate outstanding convertible preferred stock warrants converted into 64,003 common stock warrants with an exercise price of $8.64 per share, which resulted in the reclassification of the convertible preferred stock warrant liability of $0.5 million to additional paid-in capital. In September 2021, all of these common stock warrants were net exercised into 31,460 shares of common stock.

Common Stock Warrants

In September 2021, common stock warrants to purchase 38,058 shares of the Company’s stock were net exercised into 33,188 shares of common stock, which resulted in the reclassification of the common stock warrant liability of $1.2 million to additional paid-in capital.